Rob Davis, Merck CEO (Jeenah Moon/Bloomberg via Getty Images)

An­oth­er quar­ter, an­oth­er Keytru­da win for Mer­ck

Mer­ck post­ed yet an­oth­er strong quar­ter on the back of its can­cer ther­a­py Keytru­da, in what’s be­com­ing al­most a rou­tine event for the New Jer­sey …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.